Victoria E. Anderson

TL;DR: In this article, the authors evaluated the effects of therapeutic-dose low-molecular-weight heparin (LMWH) vs institutional standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19.

TL;DR: The antidote expert recommendations provide a tool to be used in creating practices for appropriate and adequate antidote stocking in hospitals that provide emergency care.

TL;DR: Treatment with FabAV reduces limb disability measured by the Patient‐Specific Functional Scale 14 days after copperhead envenomation, and additional outcome assessments generally favored FabAV.

TL;DR: A minority of subjects treated with 4 g/day of acetaminophen for at least 16 days will have low-grade aminotransferase elevations that are not accompanied by liver dysfunction and resolve if administration is continued.

TL;DR: PPA are detectable in the vast majority of subjects taking therapeutic doses of paracetamol, well below the threshold associated with hepatotoxicity, and concentrations may approach 1.1 μmol l(-1) in rare cases.